A drug that prolongs the survival of 67% of patients
Barcelona15% of all breast cancer cases diagnosed in the world are of the metastatic HER2+ (HER2+) type, which is characterized by high aggressiveness and
Source: hardwoodparoxysm.com
Javier Cort News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Javier Cort. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Javier Cort Today - Breaking & Trending Today
New treatment regimens improve outlook for patients with HER2-positive breast cancer
Tremendous progress has been made in the treatment landscape for HER2-positive breast cancer that has significantly altered and improved the outlook for this patient population.
Source: healio.com
MEDSIR & Debiopharm Initiate Clinical Collaboration to Explore Potential Synergy of Debio 0123 & Sacituzumab Govitecan in Advanced Breast Cancer
The WIN-B is a Phase Ib/II investigator-sponsored trial (IST) that will evaluate the safety and preliminary efficacy of the Debiopharm's potent Wee-1 inhibitor Debio 0123 in combination with Gilead's
Source: finanznachrichten.de
This is the Andalusian village with more bars per inhabitant than anywhere else in Spain
With 11 eateries for a population of 690, the village enters the national Guinness record book
Source: surinenglish.com
T-DXd Continues to Show Robust CNS Activity in HER2+ Breast Cancer With Brain Metastases
Javier Cortés, MD, PhD, expands on the importance of investigating the central nervous system activity of trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases; key efficacy data from the pooled analysis of the agent in the DESTINY-Breast01, -02 and -03 trials; and more.
Source: onclive.com